Bayer CEO: Corporate bureaucracy belongs in the 19th century. Here’s how we’re fighting it
Adverse jury decisions and a pipeline setback have sent Bayer's share price to a nearly 20-year low.
Tomas Kauer 
Adverse jury decisions and a pipeline setback have sent Bayer's share price to a nearly 20-year low. Read More
